Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasm Metastasis × Escitalopram × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Liver Neoplasms 1 Gallbladder Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1 ENT Cancer 1 Depressive Disorder, Major 1 Depression 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Bile Duct Neoplasms 1

Interventions

Leucovorin 21 Fluorouracil 21 Capecitabine 20 Docetaxel 18 Gemcitabine 17 Paclitaxel 16 Radiosurgery 14 Irinotecan 14 Oxaliplatin 12 Carboplatin 12 Zoledronic Acid 11 Cisplatin 11 Bevacizumab 11 Radiotherapy 10 Fulvestrant 10 Drug Therapy 9 pembrolizumab 8 palbociclib 8 Pemetrexed 8 Surgical Procedures, Operative 7 Ibandronic Acid 7 abemaciclib 6 Prednisone 6 Letrozole 6 130-nm albumin-bound paclitaxel 6 Vinorelbine 5 Folfox protocol 5 Floxuridine 5 Doxorubicin 5 Cetuximab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04763135 2023-06-08

MIR-P

Hospices Civils de Lyon

Phase 3 Terminated

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡